Momenta Pharmaceuticals, Inc. (MNTA)

[biopearl]

Given that Dr. Wheeler and Co received the warning letter one week ago, I do think it is reasonable at this point for the company to inform us as to what the scope of the current problems are. There is nothing on the FDA web site despite Dr. Wheeler's suggestion that the letter might be posted within a day or so of the announcement. That of course is the FDAs responsibility. I do think Momenta has a responsibility to its shareholders to make public the issues at hand and what remedies are planned. Maybe they will invoke confidentiality for competitive reasons. That Sandoz chose a plant with so many apparent red flags for such an important production assignment is baffling. With all the disclaimers listed by Momenta about how they can't take responsibility for their partners actions it seems unlikely that shareholders will have any recourse. At the very least we should be able to review the FDA warning letter, redactions and all. bp